Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Impressive data: zanubrutinib for Waldenström’s macroglobulinemia

Judith Trotman, MBChB, FRACP, FRCPA, of the University of Sydney School of Medicine, Sydney, Australia, discusses exciting data in the use of zanubrutinib for Waldenström’s macroglobulinemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).